(Q44127590)

30 November 2017

title

Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma (English)

1 reference

30 November 2017

0 references

0 references

1 reference

Sunil K Chhabra

1

1 reference

30 November 2017

Kamal K Pandey

series ordinal

2

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

39

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

375-381

1 reference

Regular inhaled beta-agonist treatment in bronchial asthma.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

The use of beta-agonists and the risk of death and near death from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Influence of age on response to ipratropium and salbutamol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Salbutamol and ipratropium in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Nebulized ipratropium in the treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Ipratropium bromide in acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

A Comparative Study of Various Combinations of Ipratropium Bromide and Metaproterenol in Allergic Asthmatic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

A place for ipratropium bromide in the treatment of severe acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Update on the management of status asthmaticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

Maximum achievable bronchodilatation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004030

21 January 2018

Identifiers

DOI

10.1081/JAS-120004030

1 reference

30 November 2017

1 reference